Home › Markets › Health Care › FTRE

Fortrea Holdings Inc. (FTRE)

FTRE trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$20.92
-0.38% on the day
Market cap
$2.0B
Small cap
Revenue · 2025
$2.7B
+1.0% on 2024
Net income · 2025
-$989.0M
-36.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerFTRE on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001965040
SEC industry codeServices-Medical Laboratories

Financials · 2025

LineValue
Revenue$2.7B
Net income-$989.0M
Operating income-$872.6M
Net margin-36.3%
Operating margin-32.0%
Revenue growth+1.0%
Cash$174.6M
Total assets$2.7B
P/E (computed)Net income was not positive
P/S (computed)0.7×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentDRS2023-02-13
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-07-29
Latest current report8-K2026-09-30
Latest proxyDEFA14A2026-04-27

Source: SEC EDGAR submissions feed, 336 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.2%
1 month+7.6%
3 months+18.4%
Year to date+23.0%
1 year+116.1%
From 52-week high0.0%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
ALHCAlignment Healthcare Inc.$8.30+2.60%$1.7B
PSNLPersonalis Inc.$15.85+0.32%$1.7B
CLOVClover Health Investments Corp.$4.81+0.63%$2.6B
ACHCAcadia Healthcare Company Inc.$30.23+0.50%$2.8B
FRNMFreenome Inc.$12.64-4.39%$1.4B
CELCCelcuity Inc.$63.19-4.04%$3.1B
CDNACareDx Inc.$65.43+3.66%$3.4B
TRUPTrupanion Inc.$26.57+1.06%$1.2B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier